Related Experiment Video
Updated: Feb 4, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Identification of Modulators That Activate the Constitutive Androstane Receptor From the Tox21 10K Compound Library
Caitlin Lynch1, Bryan Mackowiak2, Ruili Huang1
1Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892.
Abstract:
The constitutive androstane receptor (CAR; NR1I3) is a nuclear receptor involved in all phases of drug metabolism and disposition. However, recently it's been implicated in energy metabolism, tumor progression, and cancer therapy as well. It is, therefore, important to identify compounds that induce human CAR (hCAR) activation to predict drug-drug interactions and potential therapeutic usage. In this study, we screen the Tox21 10,000 compound collection to characterize hCAR activators. A potential novel structural cluster of compounds was identified, which included nitazoxanide and tenonitrozole, whereas known structural clusters, such as flavones and prazoles, were also detected. Four compounds, neticonazole, diphenamid, phenothrin, and rimcazole, have been identified as novel hCAR activators, one of which, rimcazole, shows potential selectivity toward hCAR over its sister receptor, the pregnane X receptor (PXR). All 4 compounds translocated hCAR from the cytoplasm into the nucleus demonstrating the first step to CAR activation. Profiling these compounds as hCAR activators would enable an estimation of drug-drug interactions, as well as identify prospective therapeutically beneficial drugs.
Insights
Researchers screened 10,000 compounds to find activators of the human constitutive androstane receptor (hCAR). Four novel activators were identified, including rimcazole, which may selectively target hCAR for drug interaction and therapy predictions.
Area of Science:
- Pharmacology
- Molecular Biology
- Drug Metabolism
Background:
- The constitutive androstane receptor (CAR; NR1I3) is a nuclear receptor crucial for drug metabolism and disposition.
- Emerging roles for CAR in energy metabolism, tumor progression, and cancer therapy highlight the need for identifying its modulators.
Purpose of the Study:
- To screen a large compound library for novel human CAR (hCAR) activators.
- To characterize the identified hCAR activators for potential drug-drug interactions and therapeutic applications.
Main Methods:
- Screening of the Tox21 10,000 compound collection to identify hCAR activators.
- Characterization of novel structural clusters and known compound classes activating hCAR.
- Assessment of nuclear translocation of hCAR induced by identified compounds.
Main Results:
- A novel structural cluster of hCAR activators, including nitazoxanide and tenonitrozole, was identified.
- Four compounds—neticonazole, diphenamid, phenothrin, and rimcazole—were characterized as novel hCAR activators.
- Rimcazole demonstrated potential selectivity for hCAR over the pregnane X receptor (PXR).
- All identified compounds induced hCAR translocation from the cytoplasm to the nucleus.
Conclusions:
- The identification of novel hCAR activators provides tools for predicting drug-drug interactions.
- These findings offer potential therapeutic agents for various diseases, including cancer.
- Profiling hCAR activators is essential for drug development and personalized medicine.
More Related Videos
Related Concept Videos
Internal Receptors
Organic Compounds
Constitutional Isomers of Alkanes
The linear isomer of an alkane is prefixed by the term “n”; hence a linear isomer of pentane is known as n-pentane. Based on the type of branching, some of the...
Coordination Compounds and Nomenclature
Formula Mass and Mole Concepts of Compounds
Constitutive and Regulated Gene Expression

